Result of Equity Issue

NMT Group PLC
14 July 2000

                                   NMT GROUP
                     RESULTS OF THE PLACING AND OPEN OFFER

              Successfully raises £24 million (net of expenses)to
           build portfolio of safety products for healthcare workers

NMT Group PLC, the manufacturer of retractable devices to prevent needlestick
injury, announces that the Open Offer to Qualifying Shareholders, described in
its prospectus dated 22 June 2000, closed at 3.00 pm on 13 July 2000.

Of the maximum 176,814,334 new Ordinary Shares to be issued pursuant to the
Placing and Open Offer, a total of 169,767,627 have been taken up by
shareholders or placed with placees.  53,333,333 new Ordinary Shares were
placed firm with institutional shareholders.  Of the 90,147,668 new Ordinary
Shares, which were placed subject to recall under the Open Offer, valid
applications in respect of 69,771,537 (77 per cent.) have been received from
Qualifying Shareholders and the remainder will be taken up by placees.

Of the 33,333,333 new Ordinary Shares, which were available under the Excess
Open Offer valid applications have been received in respect of 26,286,626 and
all applications will be allocated in full.

The Placing and Open Offer remain conditional upon admission of the new
Ordinary Shares to trading on AIM and the passing of the resolution to be
proposed at the Company's forthcoming Extraordinary General Meeting.

20,000,000 new Ordinary Shares have been allotted as part of the firm placing
to certain Venture Capital Trusts.  They are expected to be admitted to
trading on AIM at 8.30 a.m. on 19 July 2000.  The remaining 149,767,627 new
Ordinary Shares to be allotted pursuant to the Placing and Open Offer are
expected to be admitted to trading on AIM at 8.30 a.m. on 20 July 2000.

Commenting on the announcement, Roy Smith, Chief Executive of NMT, said:

'We are very pleased with the support from both existing and new shareholders.
The £20 million raised, together with the additional £4 million raised through
the Excess Offer, will help us to expand production to commercial levels of a
full range of syringes and to broaden our safety product range.'


Enquiries:

NMT Group PLC                                      Tel: [phone]
Tony Fletcher

WestLB Panmure                                     Tel: [phone]
Chris Collins / Ronald Openshaw

Financial Dynamics                                 Tel: [phone]
Sophie Pender-Cudlip / Jonathan Birt

For   further   information  on  NMT,  visit  the  company's  web   site   at:
www.nmtgroup.com